Form 8-K - Current report:
SEC Accession No. 0000950170-25-084663
Filing Date
2025-06-11
Accepted
2025-06-11 09:00:41
Documents
107
Period of Report
2025-06-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nams-20250611.htm   iXBRL 8-K 57047
2 EX-99.1 nams-ex99_1.htm EX-99.1 100727
3 GRAPHIC nams-ex99_1s1.jpg GRAPHIC 340268
4 GRAPHIC nams-ex99_1s2.jpg GRAPHIC 882549
5 GRAPHIC nams-ex99_1s3.jpg GRAPHIC 283499
6 GRAPHIC nams-ex99_1s4.jpg GRAPHIC 311828
7 GRAPHIC nams-ex99_1s5.jpg GRAPHIC 220487
8 GRAPHIC nams-ex99_1s6.jpg GRAPHIC 298185
9 GRAPHIC nams-ex99_1s7.jpg GRAPHIC 313426
10 GRAPHIC nams-ex99_1s8.jpg GRAPHIC 415131
11 GRAPHIC nams-ex99_1s9.jpg GRAPHIC 371370
12 GRAPHIC nams-ex99_1s10.jpg GRAPHIC 362296
13 GRAPHIC nams-ex99_1s11.jpg GRAPHIC 353228
14 GRAPHIC nams-ex99_1s12.jpg GRAPHIC 277228
15 GRAPHIC nams-ex99_1s13.jpg GRAPHIC 370584
16 GRAPHIC nams-ex99_1s14.jpg GRAPHIC 407901
17 GRAPHIC nams-ex99_1s15.jpg GRAPHIC 285756
18 GRAPHIC nams-ex99_1s16.jpg GRAPHIC 443301
19 GRAPHIC nams-ex99_1s17.jpg GRAPHIC 348373
20 GRAPHIC nams-ex99_1s18.jpg GRAPHIC 399183
21 GRAPHIC nams-ex99_1s19.jpg GRAPHIC 217421
22 GRAPHIC nams-ex99_1s20.jpg GRAPHIC 210981
23 GRAPHIC nams-ex99_1s21.jpg GRAPHIC 386447
24 GRAPHIC nams-ex99_1s22.jpg GRAPHIC 581826
25 GRAPHIC nams-ex99_1s23.jpg GRAPHIC 330734
26 GRAPHIC nams-ex99_1s24.jpg GRAPHIC 327412
27 GRAPHIC nams-ex99_1s25.jpg GRAPHIC 375333
28 GRAPHIC nams-ex99_1s26.jpg GRAPHIC 398918
29 GRAPHIC nams-ex99_1s27.jpg GRAPHIC 430563
30 GRAPHIC nams-ex99_1s28.jpg GRAPHIC 311806
31 GRAPHIC nams-ex99_1s29.jpg GRAPHIC 368778
32 GRAPHIC nams-ex99_1s30.jpg GRAPHIC 286943
33 GRAPHIC nams-ex99_1s31.jpg GRAPHIC 280692
34 GRAPHIC nams-ex99_1s32.jpg GRAPHIC 299833
35 GRAPHIC nams-ex99_1s33.jpg GRAPHIC 392938
36 GRAPHIC nams-ex99_1s34.jpg GRAPHIC 401328
37 GRAPHIC nams-ex99_1s35.jpg GRAPHIC 261927
38 GRAPHIC nams-ex99_1s36.jpg GRAPHIC 226312
39 GRAPHIC nams-ex99_1s37.jpg GRAPHIC 249369
40 GRAPHIC nams-ex99_1s38.jpg GRAPHIC 246259
41 GRAPHIC nams-ex99_1s39.jpg GRAPHIC 302738
42 GRAPHIC nams-ex99_1s40.jpg GRAPHIC 298409
43 GRAPHIC nams-ex99_1s41.jpg GRAPHIC 358846
44 GRAPHIC nams-ex99_1s42.jpg GRAPHIC 314840
45 GRAPHIC nams-ex99_1s43.jpg GRAPHIC 324000
46 GRAPHIC nams-ex99_1s44.jpg GRAPHIC 360131
47 GRAPHIC nams-ex99_1s45.jpg GRAPHIC 210096
48 GRAPHIC nams-ex99_1s46.jpg GRAPHIC 256692
49 GRAPHIC nams-ex99_1s47.jpg GRAPHIC 307043
50 GRAPHIC nams-ex99_1s48.jpg GRAPHIC 296823
51 GRAPHIC nams-ex99_1s49.jpg GRAPHIC 209627
52 GRAPHIC nams-ex99_1s50.jpg GRAPHIC 334488
53 GRAPHIC nams-ex99_1s51.jpg GRAPHIC 308140
54 GRAPHIC nams-ex99_1s52.jpg GRAPHIC 392368
55 GRAPHIC nams-ex99_1s53.jpg GRAPHIC 302686
56 GRAPHIC nams-ex99_1s54.jpg GRAPHIC 336643
57 GRAPHIC nams-ex99_1s55.jpg GRAPHIC 361194
58 GRAPHIC nams-ex99_1s56.jpg GRAPHIC 299918
59 GRAPHIC nams-ex99_1s57.jpg GRAPHIC 267082
60 GRAPHIC nams-ex99_1s58.jpg GRAPHIC 292832
61 GRAPHIC nams-ex99_1s59.jpg GRAPHIC 206561
62 GRAPHIC nams-ex99_1s60.jpg GRAPHIC 178985
63 GRAPHIC nams-ex99_1s61.jpg GRAPHIC 170399
64 GRAPHIC nams-ex99_1s62.jpg GRAPHIC 365155
65 GRAPHIC nams-ex99_1s63.jpg GRAPHIC 327693
66 GRAPHIC nams-ex99_1s64.jpg GRAPHIC 397529
67 GRAPHIC nams-ex99_1s65.jpg GRAPHIC 378799
68 GRAPHIC nams-ex99_1s66.jpg GRAPHIC 331852
69 GRAPHIC nams-ex99_1s67.jpg GRAPHIC 271940
70 GRAPHIC nams-ex99_1s68.jpg GRAPHIC 377816
71 GRAPHIC nams-ex99_1s69.jpg GRAPHIC 172958
72 GRAPHIC nams-ex99_1s70.jpg GRAPHIC 272315
73 GRAPHIC nams-ex99_1s71.jpg GRAPHIC 172137
74 GRAPHIC nams-ex99_1s72.jpg GRAPHIC 268527
75 GRAPHIC nams-ex99_1s73.jpg GRAPHIC 274422
76 GRAPHIC nams-ex99_1s74.jpg GRAPHIC 211403
77 GRAPHIC nams-ex99_1s75.jpg GRAPHIC 228492
78 GRAPHIC nams-ex99_1s76.jpg GRAPHIC 226769
79 GRAPHIC nams-ex99_1s77.jpg GRAPHIC 372096
80 GRAPHIC nams-ex99_1s78.jpg GRAPHIC 171048
81 GRAPHIC nams-ex99_1s79.jpg GRAPHIC 280960
82 GRAPHIC nams-ex99_1s80.jpg GRAPHIC 385435
83 GRAPHIC nams-ex99_1s81.jpg GRAPHIC 354892
84 GRAPHIC nams-ex99_1s82.jpg GRAPHIC 256757
85 GRAPHIC nams-ex99_1s83.jpg GRAPHIC 173375
86 GRAPHIC nams-ex99_1s84.jpg GRAPHIC 287948
87 GRAPHIC nams-ex99_1s85.jpg GRAPHIC 248426
88 GRAPHIC nams-ex99_1s86.jpg GRAPHIC 209408
89 GRAPHIC nams-ex99_1s87.jpg GRAPHIC 241907
90 GRAPHIC nams-ex99_1s88.jpg GRAPHIC 296245
91 GRAPHIC nams-ex99_1s89.jpg GRAPHIC 304640
92 GRAPHIC nams-ex99_1s90.jpg GRAPHIC 420663
93 GRAPHIC nams-ex99_1s91.jpg GRAPHIC 196959
94 GRAPHIC nams-ex99_1s92.jpg GRAPHIC 209202
95 GRAPHIC nams-ex99_1s93.jpg GRAPHIC 330908
96 GRAPHIC nams-ex99_1s94.jpg GRAPHIC 277087
97 GRAPHIC nams-ex99_1s95.jpg GRAPHIC 194749
98 GRAPHIC nams-ex99_1s96.jpg GRAPHIC 326772
  Complete submission text file 0000950170-25-084663.txt   41345265

Data Files

Seq Description Document Type Size
99 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20250611.xsd EX-101.SCH 53340
109 EXTRACTED XBRL INSTANCE DOCUMENT nams-20250611_htm.xml XML 6274
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 251038872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)